Press Releases

NICE Appraisal for adalimumab, etanercept and infliximab for RA after failure of a previous anti-TNF

24 Nov 2008

ARMA's statement on NICE's decision on switching Anti-TNF for RA

 

BSR response to the Health Select Committee report on MMC

9 May 2008

BSR statement in support of the Lancet Report on NICE

8 May 2008

BSR statement on the sequential use of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis

April 2008

BSR statement on the NICE Appeal Committee’s decision on the use of Abatacept for the treatment of rheumatoid arthritis

April 2008

BSR Statement on Gout

 

BSR Statement on Lumiracoxib

19 November 2007

BSR statement on NICE decision on the use of Rituximab for the treatment of rheumatoid arthritis

22 August 2007

BSR statement on the NICE appeal for the use of alternative anti-TNF

12 June 2007

BSR statement on launch of Musculoskeletal Services Framework (MSF)

1 November 2006

EMEA Announcement on NSAIDS

25 October 2006

Statement on Choose and Book Keywords & Clinic Types

16 October 2006

BSR Statement on the Musculoskeletal Services Framework

8 September 2006

Sign up to NeLH Newsletter

 

BSR Statement on Vioxx

23 August 2005

BSR Statement on EMEA NSAIDs Announcement

5 August 2005

BSR Statement on EMEA Annoucement on COX II Inhibitors

26 June 2005

BSR Statement on Safety Concerns with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

10 June 2005

New research shows arthritis patients still denied treatments in health care lottery

6 June 2005

BSR Response to Report on Skin Complications with Use of TNF Alpha Blockers

7 April 2005

BSR Statement on the withdrawal of Vioxx

26 November 2004

BSR Statement on the EMEA Review of COX II Inhibitors

16 March 2005

BSR Statement on the MHRA’s Decision to Withdraw Co-proxamol

31 January 2005

BSR Statement on the Use of Acupuncture in Osteoarthritis

21 December 2004

BSR Welcomes Standards of Care Launch

15 November 2004

Statement for Calls on Osteoporosis Survey

15 October 2004

BSR Statement On Bextra Safety Concerns

10 November 2004

BSR Statement on Johnson & Johnson Actions in Remicade Labelling

12 October 2004

MHRA Letter

 

MHRA Q&A

 

BSR's Action Plan for Service Development and Change is now available

2 May 2007

BSR President Elect – Dr Deborah E Bax

31 May 2007

Guideline for Management of Gout Available Now

5 June 2007

BSR statement on the NICE Document on Abatacept for rheumatoid arthritis

2 August 2007

NPSA reissues Methotrexate guidance

July 2006

NPSA Releases Announcement in Follow Up to Oral Methotrexate Alert

29 November 2004

DH Clarifies Obligation to Provide Funding to Support Administration of Biologic Therapies

14 July 2004

Minister of State of Health Clarifies that PCTs Must Fund NICE Recommended Treatments

26 May 2004

Alcohol and Arthritis

May 2008

ARMA logo